NfL elevated levels have been observed in various neurological conditions, including Alzheimer's disease, mild cognitive impairment, frontotemporal dementia, amyotrophic lateral sclerosis, and multiple sclerosis (40–44). Here, NEFL is linked to early-onset autosomal dominant Alzheimer disease.